Scinovex
articleTop 1% cited

A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer

JNCI Journal of the National Cancer Institute · 1994 · Vol. 86(9) · pp. 673–680
Jack A. RothFrank V. FossellaR. KomakiMichael RyanJoe B. PutnamJ. S. LeeHari M. DhingraL. DeMartin ChasenMalcolm H. McGavranE. Neely AtkinsonW. K. Hong

Abstract

This clinical trial strengthens the validity of using perioperative chemotherapy in the management of patients with resectable stage IIIA non-small-cell lung cancer. Further investigation of the perioperative chemotherapy strategy in earlier stage lung cancer is warranted.

Lung Cancer Diagnosis and TreatmentLung Cancer Treatments and MutationsMetastasis and carcinoma case studiesMedicinePerioperativeChemotherapySurgeryLung cancerRandomized controlled trialStage (stratigraphy)Induction chemotherapyClinical trialInterim analysis

MeSH terms

Antineoplastic Combined Chemotherapy ProtocolsCarcinoma, Non-Small-Cell LungCisplatinCyclophosphamideFemaleHumansLung NeoplasmsMaleMiddle AgedNeoplasm StagingProspective StudiesRemission InductionStatistics as TopicTime FactorsEpirubicin
Citations
1,113
FWCI
38.77
field-weighted impact
References
0
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer · Scinovex